APA (7th ed.) Citation

B, G., D, S. d. U., M, N., F, G., X, B., I, A., . . . P, A. (2020). Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease. Aging cell, 19(8), e13183. https://doi.org/10.1111/acel.13183

Chicago Style (17th ed.) Citation

B, Gómez-Santos, et al. "Liver Osteopontin Is Required to Prevent the Progression of Age-related Nonalcoholic Fatty Liver Disease." Aging Cell 19, no. 8 (2020): e13183. https://doi.org/10.1111/acel.13183.

MLA (9th ed.) Citation

B, Gómez-Santos, et al. "Liver Osteopontin Is Required to Prevent the Progression of Age-related Nonalcoholic Fatty Liver Disease." Aging Cell, vol. 19, no. 8, 2020, p. e13183, https://doi.org/10.1111/acel.13183.